PRECLINICAL PHARMACOLOGY OF TP1, A NOVEL POTENT TRIPLE REUPTAKE INHIBITOR WITH ANTIDEPRESSANT PROPERTIESTIAN, J.-W; JIANG, W.-L; ZHONG, Y et al.Neuroscience. 2011, Vol 196, pp 124-130, issn 0306-4522, 7 p.Article

Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezingINOUE, Takeshi; NAKAGAWA, Shin; IZUMI, Takeshi et al.European journal of pharmacology. 2006, Vol 540, Num 1-3, pp 91-95, issn 0014-2999, 5 p.Article

Citalopram in the treatment of dysthymic disorderHELLERSTEIN, David J; BATCHELDER, Sarai; MIOZZO, Ruben et al.International clinical psychopharmacology. 2004, Vol 19, Num 3, pp 143-148, issn 0268-1315, 6 p.Article

Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitorsZHENG, Yong-Yong; LIN GUO; ZHEN, Xue-Chu et al.European journal of medicinal chemistry. 2012, Vol 54, pp 123-136, issn 0223-5234, 14 p.Article

Role of fluoxetine in anorexia nervosaKIM, Sara S.The Annals of pharmacotherapy. 2003, Vol 37, Num 6, pp 890-892, issn 1060-0280, 3 p.Article

Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopramDEUPREE, Jean D; MONTGOMERY, Megan D; BYLUND, David B et al.European journal of pharmacology. 2007, Vol 576, Num 1-3, pp 55-60, issn 0014-2999, 6 p.Article

Vasomotor symptoms in menopause : physiologic condition and central nervous system approaches to treatmentRAPKIN, Andrea J.American journal of obstetrics and gynecology. 2007, Vol 196, Num 2, pp 97-106, issn 0002-9378, 10 p.Article

4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitorsPECHULIS, Anthony D; BECK, James P; KLOS, Andrew M et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 23, pp 7219-7222, issn 0960-894X, 4 p.Article

Serotonin Syndrome Risks When Combining SSRI/SNRI Drugs and Triptans : Is the FDA's Alert Warranted?WENZEL, Richard G; TEPPER, Stewart; KORAB, William E et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 11, pp 1692-1696, issn 1060-0280, 5 p.Article

Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze : the role of the serotonin transporterTROELSEN, K. B; NIELSEN, E. O; MIRZA, N. R et al.Psychopharmacologia. 2005, Vol 181, Num 4, pp 741-750, issn 0033-3158, 10 p.Article

3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitorsVU, An T; COHN, Stephen T; JOHNSTON, Grace H et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 9, pp 2464-2467, issn 0960-894X, 4 p.Article

Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim testANDREASEN, Jesper T; NIELSEN, Eisebet O; CHRISTENSEN, Jeppe K et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 10, pp 1347-1356, issn 0269-8811, 10 p.Article

Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functionsGANG ZHAO; ZANG, Shao-Yun; ZHENG, Xiang-Wei et al.Biochemical pharmacology. 2008, Vol 75, Num 9, pp 1835-1847, issn 0006-2952, 13 p.Article

Probable Association of an Attack of Bilateral Acute Angle-Closure Glaucoma With DuloxetineSHIFERA, Amde Selassie; LEONCAVALLO, Anthony; SHERWOOD, Mark et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 7, pp 936-939, issn 1060-0280, 4 p.Article

In vitro and in vivo reproduction toxicology of 12 monoaminergic reuptake inhibitors: Possible mechanisms of infrequent cardiovascular anomaliesSLOOT, Willem N; CLARE BOWDEN, H; YIH, Tjong D et al.Reproductive toxicology (Elmsford, NY). 2009, Vol 28, Num 2, pp 270-282, issn 0890-6238, 13 p.Conference Paper

A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depressionDUBE, Sanjay; DELLVA, Mary Anne; JONES, Marcia et al.Journal of psychiatric research. 2010, Vol 44, Num 6, pp 356-363, issn 0022-3956, 8 p.Article

Paroxetine use during pregnancy : Is it safe?THORMAHLEN, Genine M.The Annals of pharmacotherapy. 2006, Vol 40, Num 10, pp 1834-1837, issn 1060-0280, 4 p.Article

The importance of drug―drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in FranceMONTASTRUC, Francois; SOMMET, Agnès; BONDON-GUITTON, Emmanuelle et al.European journal of clinical pharmacology. 2012, Vol 68, Num 5, pp 767-775, issn 0031-6970, 9 p.Article

Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050SHAW, Amanda M; BOULES, Mona; YIQUN ZHANG et al.European journal of pharmacology. 2007, Vol 555, Num 1, pp 30-36, issn 0014-2999, 7 p.Article

Tolerability and safety of fluvoxamine and other antidepressantsWESTENBERG, H. G. M; SANDNER, C.International journal of clinical practice (Esher). 2006, Vol 60, Num 4, pp 482-491, issn 1368-5031, 10 p.Article

Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivityDE JONG, Trynke R; PATTIJ, Tommy; VEENING, Jan G et al.European journal of pharmacology. 2005, Vol 509, Num 1, pp 49-59, issn 0014-2999, 11 p.Article

Peripheral thyroid hormones and response to selective serotonin reuptake inhibitorsGITLIN, Michael; ALTSHULER, Lori L; FRYE, Mark A et al.Journal of psychiatry & neuroscience. 2004, Vol 29, Num 5, pp 383-386, issn 1180-4882, 4 p.Article

Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant SyndromeSTEVENS, Debra L.The Annals of pharmacotherapy. 2008, Vol 42, Num 9, pp 1290-1297, issn 1060-0280, 8 p.Article

Inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) et grossesse : Prescription médicamenteuse = Sélective serotonin reuptake inhibitors (SSRIs) in pregnancyTANGO, Rodrigo; BERNEY, Patricia; SCHULZ, Pierre et al.Revue médicale suisse. 2006, Vol 2, Num 61, pp 981-985, issn 1660-9379, 5 p.Article

Characteristics and Reasons Associated with Nonacceptance of Selective Serotonin-Reuptake Inhibitor TreatmentVAN GEFFEN, Erica C. G; VAN HULTEN, Rolf; BOUVY, Marcel L et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 2, pp 218-225, issn 1060-0280, 8 p.Article